Member Steps Down Before CDC Vaccine Panel Meets
A newly appointed member of the federal Advisory Committee on Immunization Practices (ACIP) withdrew from the panel hours before its first scheduled meeting on Wednesday. Dr. Michael Ross, one of eight new appointees selected by Health Secretary Robert F. Kennedy Jr., stepped down during the committee’s required financial holdings review, according to a department spokesperson.
RFK Jr. Replaced Entire Committee Earlier This Month
Earlier in June, Kennedy dismissed all 17 former members of ACIP and appointed a new panel of eight. His move drew widespread attention given his long-standing criticism of vaccine policy. Despite Ross’s exit, officials confirmed the meeting would proceed with a quorum.
Kennedy’s spokesperson noted that “the sacrifice to serve varies” and expressed appreciation for Ross’s initial commitment. The revised panel is expected to significantly influence future federal vaccine recommendations.
Meeting to Reveal Direction of New Panel
Wednesday’s meeting is the first public indication of how the restructured committee will approach vaccine guidelines. Kennedy stated earlier that two members who are publicly critical of vaccines would serve as co-chairs. However, only one name appeared on the official agenda.
The ACIP advises the CDC on recommended vaccines, insurance coverage, and school immunization policies. Its recommendations affect pharmacists, doctors, insurers, and federal vaccine programs serving millions of children.
Former Officials Raise Concerns About Process
Dr. Fiona Havers, a former senior CDC official who resigned last week, expressed concern over the panel’s new direction. She stated that Kennedy’s actions have “corrupted what was previously a transparent, evidence-based process,” and questioned the legitimacy of the new members and meeting agenda.
HHS officials defended the changes, saying the overhaul is aimed at restoring trust in a system that “failed millions during the covid-19 pandemic.”
Capitol Hill to Address Changes
The ACIP meeting coincides with a Senate hearing where Susan Monarez, President Donald Trump’s nominee to lead the CDC, is expected to face questions about the vaccine panel changes and Kennedy’s broader approach to public health policy.
The ACIP meeting is scheduled to continue through Thursday.
